IDO1 and melanoma: In the areas with tumor fields infiltrated by immune cells (CD45+/S100+ ROIs) melanomas with brain metastases (BM) showed lower expression of VISTA and IDO1 and no overexpression of genes when compared to tumors without metastases (NM) (Table 3, Figures 4b, e, f).